I don't have a lot of experience with using research papers, but I feel like people writing these articles don't either.
> In 2017, Naviaux and his team completed early clinical testing for suramin, the only drug approved in humans that can target ATP signaling and which is normally used to treat African sleeping sickness.
What's even the point of writing this? I found two papers, and the effects were so weak that it's hard to tell whether it even makes sense to pursue this further. Most results were not statistically significant, and the one that was did not come from a higher dosage.
But it's this sort of reporting that makes desperate parents give their children bleach enemas and horse dewormer.
> In 2017, Naviaux and his team completed early clinical testing for suramin, the only drug approved in humans that can target ATP signaling and which is normally used to treat African sleeping sickness.
What's even the point of writing this? I found two papers, and the effects were so weak that it's hard to tell whether it even makes sense to pursue this further. Most results were not statistically significant, and the one that was did not come from a higher dosage.
But it's this sort of reporting that makes desperate parents give their children bleach enemas and horse dewormer.